20-11-2025
Abbott is getting into the cancer-testing game with its $21 billion acquisition of Cologuard test maker Exact Sciences.
20-11-2025
A slowdown in corporate buybacks as AI players add debt could steal an important source of demand from the market.
20-11-2025
Verizon’s stock has been a major laggard and the company has failed to show annual earnings growth recently. CEO Dan Schulman says layoffs will make Verizon “faster and more focused.”
20-11-2025
The war in Ukraine has catalyzed a dramatic rerating of defense stocks in Europe.